This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;10(2):66.

doi: 10.1038/nrclinonc.2012.225. Epub 2012 Dec 11.

Gastrointestinal cancer: Screening cost effective, not treatment

Lisa Hutchinson

PMID: 23229185
DOI: 10.1038/nrclinonc.2012.225

Comment

Gastrointestinal cancer: Screening cost effective, not treatment

Lisa Hutchinson. Nat Rev Clin Oncol. 2013 Feb.

. 2013 Feb;10(2):66.

doi: 10.1038/nrclinonc.2012.225. Epub 2012 Dec 11.

Author

Lisa Hutchinson

PMID: 23229185
DOI: 10.1038/nrclinonc.2012.225

No abstract available

PubMed Disclaimer

Comment on

Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.
Behl AS, Goddard KA, Flottemesch TJ, Veenstra D, Meenan RT, Lin JS, Maciosek MV. Behl AS, et al. J Natl Cancer Inst. 2012 Dec 5;104(23):1785-95. doi: 10.1093/jnci/djs433. Epub 2012 Nov 28. J Natl Cancer Inst. 2012. PMID: 23197490 Free PMC article.

References

1. J Natl Cancer Inst. 2012 Dec 5;104(23):1785-95 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.